Last Updated: 01/08/2024
Change of G6PD activity in the course of malaria
Objectives
This project will test whether G6PD levels increase during a malaria attack, rendering treatment much safer than what is assumed to date.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria is a serious and potentially deadly disease. Following a first symptomatic phase, some malaria species develop asymptomatic forms that cause a second symptomatic phase weeks to months after the first episode. The drugs currently used to treat this malaria species can cause severe side effects in people with low activities of a particular enzyme (G6PD).
External reference
Thematic Categories
Date
Jan 2024 — Feb 2027
Total Project Funding
$871,583
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 2028979
AUD 1.29M
Project Site
Related Resources
